Evidence map›Paper›PMID 21849094›Full record

ArticleThe British journal of nutrition2012

Benefits of whole ginger extract in prostate cancer.

Prasanthi Karna, Sharmeen Chagani, Sushma R Gundala, Padmashree C G Rida, Ghazia Asif, Vibhuti Sharma, Meenakshi V Gupta, Ritu Aneja

Open access · bronzeAbstract read
In one paragraph

Article in The British journal of nutrition, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Anticancer Properties of Garlic and Ginger Extract in Colon Cancer Cell Line.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  5. Effect of ginger, chamomile, and green tea extracts on prostate cancer cells.Journal, genetic engineering & biotechnology · 2024
    Article
  6. Review
  7. Review
  8. Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Scientific reports · 2021
    Article
  19. Prostate cancer: Therapeutic prospect with herbal medicine.Current research in pharmacology and drug discovery · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Prasanthi KarnaDepartment of Biology, Georgia State University, Atlanta, GA 30303, USA.
Sharmeen Chagani
Sushma R Gundala
Padmashree C G Rida
Ghazia Asif
Vibhuti Sharma
Meenakshi V Gupta
Ritu Aneja
Georgia State University · US

Funding

Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agentR00CA131489 · NCI · GEORGIA STATE UNIVERSITY · PI ANEJA, RITU · 2010 to 2012
$732k
NCI NIH HHS 1R00CA131489NCI NIH HHS R00 CA131489
6 · The paper itself

Abstract

It is appreciated far and wide that increased and regular consumption of fruits and vegetables is linked with noteworthy anticancer benefits. Extensively consumed as a spice in foods and beverages worldwide, ginger (Zingiber officinale Roscoe) is an excellent source of several bioactive phenolics, including non-volatile pungent compounds such as gingerols, paradols, shogaols and gingerones. Ginger has been known to display anti-inflammatory, antioxidant and antiproliferative activities, indicating its promising role as a chemopreventive agent. Here, we show that whole ginger extract (GE) exerts significant growth-inhibitory and death-inductory effects in a spectrum of prostate cancer cells. Comprehensive studies have confirmed that GE perturbed cell-cycle progression, impaired reproductive capacity, modulated cell-cycle and apoptosis regulatory molecules and induced a caspase-driven, mitochondrially mediated apoptosis in human prostate cancer cells. Remarkably, daily oral feeding of 100 mg/kg body weight of GE inhibited growth and progression of PC-3 xenografts by approximately 56 % in nude mice, as shown by measurements of tumour volume. Tumour tissue from GE-treated mice showed reduced proliferation index and widespread apoptosis compared with controls, as determined by immunoblotting and immunohistochemical methods. Most importantly, GE did not exert any detectable toxicity in normal, rapidly dividing tissues such as gut and bone marrow. To the best of our knowledge, this is the first report to demonstrate the in vitro and in vivo anticancer activity of whole GE for the management of prostate cancer.

Indexed as

Dietary SupplementsAnimalsAntineoplastic Agents, PhytogenicApoptosisApoptosis Regulatory ProteinsBiomarkersCell CycleCell Line, TumorCell ProliferationHumansMaleMiceMice, Inbred BALB CMice, NudePlant ExtractsProstatic NeoplasmsAntineoplastic Agents, PhytogenicApoptosis Regulatory ProteinsBiomarkersPlant Extracts

Identifiers

PMID21849094
PMCPMC3426621
OpenAlexW2153970880

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.